Abstract:New series of sulfonamide derivatives containing a dihydropyrazole moieties inhibitors of MMP-2/MMP-9 were discovered using structure-based drug design. Synthesis, antitumor activity, structure-activity relationship and optimization of physicochemical properties were described. In vitro the bioassay results revealed that most target compounds showed potent inhibitory activity in the enzymatic and cellular assays. Among the compounds, compound 3i exhibited the most potent inhibitory activity with IC50 values of 0.21 mu M inhibiting MMP-2 and 1.87 mu M inhibiting MMP-9, comparable to the control positive compound CMT-1 (1.26 mu M, 2.52 mu M). Docking simulation was performed to position compound 3i into the MMP-2 active site to determine the probable binding pose. Docking simulation was further performed to position compound 3i into the MMP-2 active site to determine the probable binding model the 3D-QSAR models were built for reasonable design of MMP-2/MMP-9 inhibitors at present and in future. (C) 2015 Elsevier Ltd. All rights reserved.

Design, Synthesis, and Primary Activity Evaluation of Pyrrolidine Derivatives As Matrix Metalloproteinase Inhibitors.

Design, Synthesis and Preliminary Evaluation of Novel Pyrrolidine Derivatives As Matrix Metalloproteinase Inhibitors

Synthesis of New Sulfonyl Pyrrolidine Derivatives As Matrix Metalloproteinase Inhibitors

Design, Synthesis and Preliminary Evaluation of Α-Sulfonyl Γ-(Glycinyl-amino)proline Peptidomimetics As Matrix Metalloproteinase Inhibitors.

Design, Synthesis, and Biological Evaluation of 4-Phenoxybenzenesulfonyl Pyrrolidine Derivatives As Matrix Metalloproteinase Inhibitors

[Design, synthesis and activity evaluation of novel matrix metalloproteinases inhibitors based on the structure of enzyme].

Design, Synthesis and Biological Evaluation of Novel 1,2,3,4-Tetrahydroisoquinoline-3-carboxylic Acid Derivatives As Aminopeptidase N/CD13 Inhibitors.

Advances in Matrix Metalloproteinase Inhibitors Based on Pyrrolidine Scaffold

Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors.

Protein Catabolic Enzymes Inhibitory Activities of Pyrrolidine Derivatives

Synthesis and Gelatinase (MMP-2, MMP-9) Inhibitory Activities of Pyrrolidine Derivatives

Design, Synthesis and Preliminary Evaluation of New Cinnamoyl Pyrrolidine Derivatives As Potent Gelatinase Inhibitors

Synthesis and Characterization of Pyrrolidine Derivatives As Matrix Metalloproteinase-2 Inhibitors

Design, Synthesis and Primary Activity Assay of Bi- or Tri-Peptide Analogues with the Scaffold L-Arginine As Amino-Peptidase N/CD13 Inhibitors

Design, Synthesis, and QSAR Studies of Novel Lysine Derives As Amino-Peptidase N/CD13 Inhibitors.

Synthesis and Biological Evaluation of Novel Benzofuroxan-Based Pyrrolidine Hydroxamates As Matrix Metalloproteinase Inhibitors with Nitric Oxide Releasing Activity.

Sulfonyl Phosphonic 1,4-Dithia-7-azaspiro[4,4]nonane Derivatives As Matrix Metalloproteinase Inhibitors: Synthesis, a Docking Study, and Biological Evaluation.

Design, Synthesis and Biological Evaluation of Novel Tripeptidyl Epoxyketone Derivatives Constructed from Β-Amino Acid As Proteasome Inhibitors.

The Synthesis and Preliminary Activity Assay in Vitro of Peptide-Like Derivatives As APN Inhibitors

Sulfonamide Derivatives Containing Dihydropyrazole Moieties Selectively and Potently Inhibit Mmp-2/Mmp-9: Design, Synthesis, Inhibitory Activity and 3D-Qsar Analysis

Design, synthesis and preliminary bioactivity evaluations of 8-hydroxyquinoline derivatives as matrix metalloproteinase (MMP) inhibitors.